Clinical Trial Update: Effect of Liraglutide on Vascular Inflammation in Type-2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the effect of liraglutide on vascular inflammation in type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Steno Diabetes Center Copenhagen | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED